Given that both miR-155 and IRAK-1 contribute to neuroinflammation, our findings suggest that the combination of these two SNPs might create a more pronounced inflammatory environment, thereby imposing a higher MS risk than either SNP alone. The gene discussed is IRAK1; the disease is myeloid sarcoma.